Deep Track Capital, LP
Q2 2025 13F Holdings
- Locationgreenwich, CT
- Num holdings
66
- Value ($000)
$3,118,190
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001856083
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
GH GUARDANT HEALTH INC | COM | 40131M109 | $221.17 M | 7 % | 4,250,000 | ||
ISI IONIS PHARMACEUTICALS INC | COM | 462222100 | $193.26 M | 6 % | 4,891,544 | ||
PTGX PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | $179.40 M | 6 % | 3,245,899 | ||
DVAX DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | $176.49 M | 6 % | 17,791,486 | ||
INSM INSMED INC | COM PAR $.01 | 457669307 | $176.12 M | 6 % | 1,750,000 | ||
AKRO AKERO THERAPEUTICS INC | COM | 00973Y108 | $162.35 M | 5 % | 3,042,598 | ||
IMVT IMMUNOVANT INC | COM | 45258J102 | $152.00 M | 5 % | 9,500,000 | ||
OCUL OCULAR THERAPEUTIX INC | COM | 67576A100 | $132.65 M | 4 % | 14,294,420 | ||
APLS APELLIS PHARMACEUTICALS INC | COM | 03753U106 | $121.17 M | 4 % | 7,000,000 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $120.60 M | 4 % | 3,650,000 |
Rows Per Page
10
- 10
- 50
- 100